149 related articles for article (PubMed ID: 4217763)
1. Origin of endogenous and exogenous agents in cell cultures.
Hopps HE
In Vitro; 1974; 10(5-6):243-6. PubMed ID: 4217763
[No Abstract] [Full Text] [Related]
2. Preparation of vaccines--cell substrates.
Perkins FT
Adv Exp Med Biol; 1972; 31(0):187-96. PubMed ID: 4212264
[No Abstract] [Full Text] [Related]
3. Tissue and medium antigens in vaccines.
Coriell LL
Natl Cancer Inst Monogr; 1968 Dec; 29():179-91. PubMed ID: 4976862
[No Abstract] [Full Text] [Related]
4. Viral vaccines: various cell substrates and long-term prospective studies.
Kirschstein RL; Petricciani JC
Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515
[No Abstract] [Full Text] [Related]
5. Characteristics of primary cultures and diploid cells--technology of production.
Holper JC
Natl Cancer Inst Monogr; 1968 Dec; 29():21-31. PubMed ID: 4976359
[No Abstract] [Full Text] [Related]
6. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
Petricciani JC; Milstien JB
Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
[TBL] [Abstract][Full Text] [Related]
7. Endogenous agents in primary cell cultures with special reference to latent viruses.
Swack NS; Hsiung GD
In Vitro; 1974; 10(5-6):260-7. PubMed ID: 4375664
[No Abstract] [Full Text] [Related]
8. [Dynamics of the synthesis of tick-borne encephalitis virus antigen by cell cultures of varying origins according to immunofluorescence data].
Shukhmina NR; Bogomolova NN; Andzhaparidze OG
Vopr Virusol; 1974; (4):470-4. PubMed ID: 4216159
[No Abstract] [Full Text] [Related]
9. Primate endogenous viruses: their role in oncogenesis and as biohazards.
Kalter SS; Heberling RL
Dev Biol Stand; 1976 Dec 13-15; 37():219-28. PubMed ID: 829599
[No Abstract] [Full Text] [Related]
10. Detection of persistent infections using biophysical methods.
Anderson NG
Natl Cancer Inst Monogr; 1968 Dec; 29():393-403. PubMed ID: 4976365
[No Abstract] [Full Text] [Related]
11. [Contaminamts of cell cultures].
Demidova SA; Ritova NM
Vopr Virusol; 1974; (5):521-7. PubMed ID: 4216160
[No Abstract] [Full Text] [Related]
12. [Conditions for creating a persistent A/swine/1976/31 infection in cell cultures].
Osipova ZA; Aron RA; Medvedeva MN
Mikrobiol Zh (1978); 1980; 42(6):735-41. PubMed ID: 6780764
[No Abstract] [Full Text] [Related]
13. Production of vaccines with special reference to rubella vaccine RA 27-3 strain in WI 38 cells.
Beale AJ
Adv Exp Med Biol; 1972; 31(0):179-86. PubMed ID: 4671959
[No Abstract] [Full Text] [Related]
14. Preparation and testing of duck embryo cell culture rubella vaccine.
Buynak EB; Larson VM; McAleer WJ; Mascoli CC; Hilleman MR
Am J Dis Child; 1969 Aug; 118(2):347-54. PubMed ID: 4307520
[No Abstract] [Full Text] [Related]
15. Markers for measles virus. II. Tissue culture properties.
Schumacher HP; Albrecht P; Tauraso NM
Arch Gesamte Virusforsch; 1972; 36(3):296-310. PubMed ID: 4623186
[No Abstract] [Full Text] [Related]
16. Veterinary vaccines.
LaSalle B
Natl Cancer Inst Monogr; 1968 Dec; 29():515-22. PubMed ID: 4305439
[No Abstract] [Full Text] [Related]
17. [Biology of attenuated mumps, rubella, measles and rabies viruses. Comparative considerations on the methods of attenuation of their virulence].
Ciaccio G
Riv Biol; 1970; 63(1):87-129. PubMed ID: 4996066
[No Abstract] [Full Text] [Related]
18. Laboratory testing in rubella vaccine control.
Hopps HE; Parkman PD; Meyer HM
Am J Dis Child; 1969 Aug; 118(2):338-45. PubMed ID: 4978512
[No Abstract] [Full Text] [Related]
19. [Testing the safety of cultural viral vaccines].
Dobrotvortseva VG; Milovidova NI
Vopr Virusol; 1981; (2):132-6. PubMed ID: 6168111
[No Abstract] [Full Text] [Related]
20. [Study of the multiplication of Tiuleniĭ, Sakhalin and Baku arboviruses in cell cultures].
Veselovskaia OV; Borisova SM; Gromashevskiĭ VL; Zakarian VA; L'vov DK
Vopr Virusol; 1973; 18(6):693-6. PubMed ID: 4789979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
